[CRISPR/Cas9 SAM (synergic activation mediator): a new strategy to screen for genome-encoded antiviral restriction factors]
Med Sci (Paris)
.
2018 May;34(5):401-403.
doi: 10.1051/medsci/20183405010.
Epub 2018 Jun 13.
[Article in French]
Authors
Blanche Dekeyzer
1
,
Marie Hoareau
1
,
Gabriel Laghlali
1
Affiliation
1
École normale supérieure de Lyon, département de biologie, Master biologie, Lyon, France.
PMID:
29900840
DOI:
10.1051/medsci/20183405010
No abstract available
MeSH terms
Animals
Antiviral Agents / pharmacology
CRISPR-Cas Systems / genetics*
Genetic Testing / methods*
Humans
Virus Diseases / immunology*
Substances
Antiviral Agents